Literature DB >> 28333348

Promoter characterization and expression of the blaKPC-2 gene in Escherichia coli, Pseudomonas aeruginosa and Acinetobacter baumannii.

Delphine Girlich1,2, Rémy A Bonnin1,2, Agnes Jousset1,2, Thierry Naas1,2.   

Abstract

Objectives: KPC-producing pathogens exhibit variable carbapenem susceptibility levels, which is probably the result of the genetic environment of the bla KPC genes. Here we determined the transcriptional start sites (TSSs) and the expression of the bla KPC-2 gene in various genetic contexts and in different hosts ( Escherichia coli , Pseudomonas aeruginosa and Acinetobacter baumannii ).
Methods: The bla KPC-2 genes along with the upstream sequences derived from Tn 4401b (structure A), Tn 4401b interrupted by Tn 3 /IS 26 (structure B) and Tn 4401b interrupted by Tn 5563 (structure C) were cloned in two E. coli shuttle vectors (pBBR1MCS.3 for expression studies in P. aeruginosa and pIM-arr2 for expression studies in A. baumannii ). MICs were determined by Etests. 5' RACE (where RACE stands for rapid amplification of cDNA ends) and quantitative RT-PCR experiments were performed to determine TSSs and transcription levels, respectively.
Results: Depending on the bacterial host, different promoters were used for bla KPC-2 gene expression. The highest transcriptional level was obtained in P. aeruginosa with structure C, described only in P. aeruginosa . Tn 4401b (structure A), harbouring two promoters (P1 and P2), was the most efficient in E. coli and A. baumannii . This structure was also efficient in P. aeruginosa , although the same deduced promoter was not used (P1, instead of P2 used by E. coli and A. baumannii ). Two novel TSSs and putative promoters (P2b and P3b) were identified in structure B. In this structure, P2b and P3b were preferably used in E. coli and in P. aeruginosa , respectively, whereas P1 was used in A. baumannii . Conclusions: We determined the preferred TSSs of the bla KPC gene in each species and described two novel deduced promoters in structure B.
© The Author 2017. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28333348     DOI: 10.1093/jac/dkx044

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  4 in total

1.  Molecular Characterization of OXA-198 Carbapenemase-Producing Pseudomonas aeruginosa Clinical Isolates.

Authors:  Rémy A Bonnin; Pierre Bogaerts; Delphine Girlich; Te-Din Huang; Laurent Dortet; Youri Glupczynski; Thierry Naas
Journal:  Antimicrob Agents Chemother       Date:  2018-05-25       Impact factor: 5.191

2.  Emergence of New Non-Clonal Group 258 High-Risk Clones among Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae Isolates, France.

Authors:  Rémy A Bonnin; Agnès B Jousset; Adriana Chiarelli; Cécile Emeraud; Philippe Glaser; Thierry Naas; Laurent Dortet
Journal:  Emerg Infect Dis       Date:  2020-06       Impact factor: 6.883

3.  Undetectable Production of the VIM-1 Carbapenemase in an Atlantibacter hermannii Clinical Isolate.

Authors:  Delphine Girlich; Rémy A Bonnin; Alexis Proust; Thierry Naas; Laurent Dortet
Journal:  Front Microbiol       Date:  2021-12-20       Impact factor: 5.640

4.  Carbapenemase-Encoding Gene Copy Number Estimator (CCNE): a Tool for Carbapenemase Gene Copy Number Estimation.

Authors:  Jianping Jiang; Liang Chen; Xin Chen; Pei Li; Xiaogang Xu; Vance G Fowler; David van Duin; Minggui Wang
Journal:  Microbiol Spectr       Date:  2022-07-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.